Previous studies have shown that prostate cancer is a low immune-reactive cancer characterized by limited infiltration of immune cells or extensive infiltration of immunosuppressive T cells, in which the processed death-1 (PD-1) /programmed death ligand 1 (PD-L1) pathway plays an important role [2]. Here, CD274 is linked to cancer.